Skip to content

Delcath Systems DCTH Price / earnings

Price / earnings at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
Boston Scientific logo
Boston ScientificBSX
26.2×-47.5×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.4×-7.3×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
14.4×-4.1×
Exelixis logo
ExelixisEXEL
13.6×-2.4×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
15.6×-7.1×

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

Based on the most recent quarter.

The official record: Delcath Systems’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's price / earnings?
Delcath Systems (DCTH) reported price / earnings of 313.9× in Q3 2025.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.